Alira Health

Alira Health Expands North American Capabilities with Acquisition of Artisan Healthcare Consulting

Augments Company’s Strong Global Consulting Services

Alira Health, a patient-centric, global health care advisory, clinical research and technology company, announced the acquisition of Artisan Healthcare Consulting, a US-based consulting firm that provides strategic insights to healthcare companies. Artisan serves 12 of the top 15 pharmaceutical companies in the US, supports the C-Suite of leading biotechnology companies, and has deep expertise in over 30 therapeutic areas.

Artisan Healthcare Consulting’s leadership has decades of experience serving as a long-term partner to healthcare executives. We welcome them to the Alira Health team.”
Jean-Francois Ricci Chief Access Officer, Alira Health

The acquisition of Artisan strengthens and extends Alira Health’s Market Access and Management Consulting advisory practices in North America and globally. Clients of Alira Health and Artisan Healthcare Consulting now have access to the full breadth of advisory offerings from both firms. Alira Health clients can leverage Artisan’s deep expertise in brand strategy and analytics, new product differentiation, US market access, go-to-launch strategies, and product lifecycle management. Artisan Healthcare Consulting clients can benefit from Alira Health’s clinical operations, real-world evidence, and patient-centric technology offerings, including decentralized clinical trials (DCT), patient support programs (PSP) and digital therapeutics (DTx).

“Artisan Healthcare Consulting is recognized for delivering the highest level of strategic and quantitative analysis to help healthcare leaders act decisively across their business,” said Jean-Francois Ricci, Chief Access Officer at Alira Health. “Artisan Healthcare Consulting’s leadership has decades of experience serving as a long-term partner to healthcare executives. We welcome them to the Alira Health team.”

“We are delighted to join a company with such a broad and complementary set of capabilities,” said Bob Delise, CEO and Founder of Artisan Healthcare Consulting. “It is a pleasure to work with our new colleagues, and we now have access to an international team of strategists and experts who can help our customers succeed. We embrace Alira Health’s mission to humanize healthcare and look forward to offering new capabilities to all our clients.”

Artisan Healthcare Consulting partners Bob Delise, Brad Ship, and Greg Wolfe will join Alira Health’s global consulting leadership team as they continue to work with their long-term clients.

About Artisan Healthcare Consulting, Inc.:

Artisan Healthcare Consulting Inc. was founded in 2009 on the principle that outstanding client service differentiates a great consulting firm from a good one. Artisan provides strategic and analytic advice to a wide range of healthcare product companies. Artisan works across the biopharma industry to help clients steer emerging therapies through clinical development, launch them successfully, and drive success throughout the life cycle of their products.
Artisan Healthcare Consulting is based in Waltham, Massachusetts.

About Alira Health:

Alira Health is an international, patient-centric, global health care advisory, clinical research, and technology company, whose mission is to humanize healthcare. We work with healthcare and life sciences organizations looking for support across their entire solutions lifecycle. From development to medical care, we complement our clients’ expertise with a full spectrum of services including research and clinical development solutions, technology-powered consulting, and real-world evidence.

Our integrated and multidisciplinary team of over 600 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50% of MedTech companies and 75% of the top 50% of Pharma companies.

Related news

Events March 31, 2025
Swiss Biotech Day 2025
Connect with our delegates on-site to discover how we can assist you with our agile and holistic biotech solutions.
Biotech EU
Webinars March 28, 2025
How Sustainability and Health Equity Are Reshaping Market Access Policy in Europe
This webinar will explore sustainability and health equity impact on reimbursement and procurement decisions in Europe and provide practical insights on how companies can adapt to the new landscape.
EU Market Access Sustainability
Case Studies March 20, 2025
Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping
Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.
Patient Advocacy Patient Engagement Pharma
Events March 12, 2025
Healthtech Accelerations Summit 2025
Meet our experts to discover how we support companies bring innovation to patients by structuring drug development into clear, achievable inflection points.
Biotech Drug Development EU Healthcare Technology
Case Studies March 6, 2025
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Patient Centricity Pharma Rare Disease
Articles March 6, 2025
ATMPs: Access, Pricing, and Ethical Issues in Perspective
Start reading this sneak peek of our recent analysis of access, pricing and ethical issues for advanced therapies medicinal products.
Advanced Therapies Market Access Orphan Drug Pricing
Events February 18, 2025
BIO-Europe Spring 2025
Learn how can we support your planning, funding, and executing processes, both strategically and technically, to successfully bring your innovation to patients.
Biotech EU
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.